Lack of Significant Effect of Bilastine Administered at Therapeutic and Supratherapeutic Doses and Concomitantly With Ketoconazole on Ventricular Repolarization: Results of a Thorough QT Study (TQTS) With QT-Concentration Analysis-Reference-Cited by-同舟云学术

Lack of Significant Effect of Bilastine Administered at Therapeutic and Supratherapeutic Doses and Concomitantly With Ketoconazole on Ventricular Repolarization: Results of a Thorough QT Study (TQTS) With QT-Concentration Analysis

Published:2012-06 Issue:6 Volume:52 Page:893-903
ISSN:0091-2700
Container-title:The Journal of Clinical Pharmacology
language:en
Short-container-title:

Author:

Tyl Benoît,Kabbaj Meriam,Azzam Sara,Sologuren Ander,Valiente Román,Reinbolt Elizabeth,Roupe Kathryn,Blanco Nathalie,Wheeler William

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1177/0091270011407191/fullpdf

Reference35 articles.

1. Preclinical pharmacology of bilastine, a new selective histamine H1 receptor antagonist: receptor selectivity and in vitro antihistaminic activity;Corcóstegui;Drugs R D,2005

2. Comparison of peripheral and central effects of single and repeated oral dose administrations of bilastine, a new H1 antihistamine: a dose-range study in healthy volunteers with hydroxyzine and placebo as control treatments;García-Gea;J Clin Psychopharmacol,2008

3. Pros and cons of the use of antihistamines in managing allergic rhinitis;Day;J Allergy Clin immunol,1999

4. Comparison of the efficacy and safety of bilastine 20 mg vs desloratadine 5 mg in seasonal allergic rhinitis patients;Bachert;Allergy,2009

5. Efficacy and safety of bilastine 20 mg compared with cetirizine 10 mg and placebo for the symptomatic treatment of seasonal allergic rhinitis: a randomized, double-blind, parallel-group study;Kuna;Clin Exp Allergy,2009

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bioequivalence and Safety of Bilastine 20 mg Orodispersible Tablets and Conventional Tablets: A Randomized, Single-Dose, Two-Period Crossover Study in Healthy Volunteers Under Fasting Conditions;Drugs in R&D;2024-08-01

2. Comparison of the Efficacy and Safety of Bilastine 20 mg versus Fexofenadine 180 mg for Treatment of Perennial Allergic Rhinitis: Randomized Controlled Study;Indian Journal of Otolaryngology and Head & Neck Surgery;2024-06-01

3. Bilastine for the treatment of allergic rhinoconjunctivitis and urticaria: results from an international Delphi study;Drugs in Context;2024-05-01

4. Efficacy and safety of fixed-dose combination of Bilastine-Montelukast in adult patients with allergic rhinitis: a phase III, randomized, multi-center, double-blind, active controlled clinical study;Journal of Asthma;2023-05-31

5. An international Delphi study on the burden of allergic rhinoconjunctivitis and urticaria and the role of bilastine among current treatment options;Expert Review of Clinical Immunology;2023-05-24